Research Overview
CJC-1295 with Drug Affinity Complex (DAC) is a modified GHRH analog designed for extended receptor engagement studies. The DAC modification facilitates albumin binding, extending plasma half-life in in vitro models. Studied for GH secretagogue receptor binding kinetics and prolonged signaling research.
Compound Specifications
| Molecular Formula | C₁₅₂H₂₅₂N₄₂O₄₂S |
|---|---|
| Molecular Weight | 3,647.3 Da |
| CAS Number | 863288-34-0 |
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ + DAC |
| Purity | >99% (HPLC verified) |
| Storage | Store at -20°C. Stable 24 months lyophilized. |
| Form | Lyophilized powder |
Certificate of Analysis
Each batch is third-party tested. COA available upon request — contact us with your order number.
⚠ RESEARCH USE ONLY — This product is sold exclusively for in vitro laboratory research purposes. It is not intended for human or veterinary use, consumption, injection, or any clinical application. Not for sale to minors. By purchasing, you confirm you are a qualified research professional aged 21 or older.
Reviews
There are no reviews yet.